ANONYMOUS: "Amgen presents denosumab and sclerostin antibody data at American Society for Bone and Mineral Research Annual Meeting", AMGEN MEDIA PRESS RELEASE, 2006, pages 1-3, XP002517455, Retrieved from the Internet: URL:www.amgen.com/media/media_pr_detail.js p?releaseID=907028 [retrieved on 2009-02-26] (B1)

ANONYMOUS: "UCB on track", UCB NEWS, 14 December 2007 (2007-12-14), pages 1/3-3/3, XP002517457, Retrieved from the Internet: URL:http://hugin.info/133973/R/1176122/233 395.pdf [retrieved on 2009-03-03] (B1)

GAZZERRO ET AL: "Potential drug targets within bone morphogenetic protein signaling pathways", CURRENT OPINION IN PHARMACOLOGY, vol. 7, May 2007 (2007-05), pages 325-333, XP022078332, (B1)

LI ET AL: "Treatment with an anti-sclerostin antibody increases bone mass by stimulating bone formation without increasing bone resorption in aged male rats", JOURNAL OF BONE AND MINERAL RESEARCH, vol. 22 (suppl. 1), September 2007 (2007-09), page S36, XP002689216, (B1)

LÖWIK ET AL: "Wnt signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation", JOURNAL OF MUSCULOSKELETAL AND NEURONAL INTERACTIONS, vol. 6, 2006, page 357, XP002517456, (B1)

WO-A2-2006/119107 (B1)

OMINSKY ET AL: "Sclerostin monoclonal antibody treatment increases bone strength in aged osteopenic ovariectomized rats", JOURNAL OF BONE AND MINERAL RESEARCH, vol. 21 (suppl. 1), 2006, page S44, XP002689214, (B1)

PADHI ET AL: "Anti-sclerostin antibody increases markers of bone formation in healthy postmenopausal women", JOURNAL OF BONE AND MINERAL RESEARCH, vol. 22 (Suppl. 1), September 2007 (2007-09), page S37, XP002689215, (B1)

PADHI ET AL: "Anti-sclerostin antibody increases markers of bone formation in healthy postmenopausal women", Oasis, Online Abstract Submission and Invitation System, 18 September 2007 (2007-09-18), page 1, XP002517555, Retrieved from the Internet: URL:www.abstractsonline.com/viewer/SearchR esults.asp [retrieved on 2009-03-03] (B1)

PADHI ET AL: "OC35 - Effects of anti-sclerostin monoclonal antibody in healthy postmenopausal women", OSTEOPOROSIS INTERNATIONAL / SUPPLEMENT 1, vol. 19, 20 March 2008 (2008-03-20), page S19, XP002517556, (B1)

REB: "Antikörper gegen Sclerostin", MEDICAL TRIBUNE, vol. 39, March 2007 (2007-03), page 12, XP002689219, (B1)

MALONE ET AL: "Bone anabolism achieved by reducing sclerostin bioavailability with an anti-sclerostin antibody", 37TH INTERNATIONAL SUN VALLEY WORKSHOP ON SKELETAL TISSUE BIOLOGY, AUGUST 5TH-8TH, 2007 37TH INTERNATIONAL SUN VALLEY WORKSHOP ON SKELETAL TISSUE BIOLOGY, AUGUST 5TH-8TH, 2007, pages 2-3, XP002517458, Retrieved from the Internet: URL:www.sunvalleyworkshop.org/Poster%20Pre sentations%20&%20Abstracts%202007.pdf [retrieved on 2009-02-26] (B1)